Company intelligence / Profile preview

MindRhythm

Cupertino, California, United Statesmindrhythm.com ↗

Ownership: Private
Development stage: Phase 2

Overview

MindRhythm has developed a novel noninvasive medical device ("Harmony") that uses proprietary algorithms to rapidly identify large vessel occlusion strokes in prehospital settings. The pivotal EPISODE clinical trial completed enrollment in late 2023. The technology aims to improve patient outcomes by enabling faster, more accurate triage and transport decisions for suspected stroke patients—potentially reducing time to treatment and improving survival rates. Early results have shown promise in enhancing early detection compared with standard EMS protocols.

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapy (neurodiagnostic/monitoring device)
Industry: Physiological Monitoring

Partnerships

Stanford University (clinical collaboration on technology validation/trials)

Beyond the preview

Go deeper on MindRhythm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MindRhythm.

Explore the full profile